Specific risk factors for cerebrovascular disorders in patients with chronic kidney disease in the pre-dialysis period
Cerebral vascular disorders are one of the leading causes of disability and mortality in patients with chronic kidney disease (CKD). The article presents the currently available data on risk factors (RF) for the development of cerebrovascular disorders in pre-dialysis patients with CKD. Two groups o...
Saved in:
Published in: | Kardiovaskuli͡a︡rnai͡a︡ terapii͡a︡ i profilaktika Vol. 18; no. 3; pp. 88 - 93 |
---|---|
Main Authors: | , , |
Format: | Journal Article |
Language: | English |
Published: |
SILICEA-POLIGRAF» LLC
13-06-2019
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Cerebral vascular disorders are one of the leading causes of disability and mortality in patients with chronic kidney disease (CKD). The article presents the currently available data on risk factors (RF) for the development of cerebrovascular disorders in pre-dialysis patients with CKD. Two groups of RF are identified: traditional and non-traditional (specific). Traditional RF, which include arterial hypertension, diabetes mellitus and hypercholesterolemia, independently affect the cerebral vascular bed and get worse against the background of CKD. Specific RF is associated with features of the CKD pathogenesis. It includes increased blood levels of homocysteine, β2-microglobulin, impaired calcium-phosphorus metabolism, accumulation of uremic toxins and toxins of intestinal bacteria, anemia and other factors. In the present review, special attention is paid to specific RF and pathogenetic mechanisms of the development of cerebrovascular disorders in predialysis patients with CKD. Timely detection of cerebral risk factors may lead to the improvement of early diagnosis and prevention of cerebral vascular disorders, optimization of therapy for patients with CKD. |
---|---|
AbstractList | Cerebral vascular disorders are one of the leading causes of disability and mortality in patients with chronic kidney disease (CKD). The article presents the currently available data on risk factors (RF) for the development of cerebrovascular disorders in pre-dialysis patients with CKD. Two groups of RF are identified: traditional and non-traditional (specific). Traditional RF, which include arterial hypertension, diabetes mellitus and hypercholesterolemia, independently affect the cerebral vascular bed and get worse against the background of CKD. Specific RF is associated with features of the CKD pathogenesis. It includes increased blood levels of homocysteine, β2-microglobulin, impaired calcium-phosphorus metabolism, accumulation of uremic toxins and toxins of intestinal bacteria, anemia and other factors. In the present review, special attention is paid to specific RF and pathogenetic mechanisms of the development of cerebrovascular disorders in predialysis patients with CKD. Timely detection of cerebral risk factors may lead to the improvement of early diagnosis and prevention of cerebral vascular disorders, optimization of therapy for patients with CKD. |
Author | Nikitina, A. A. Khruleva, N. S. Khrulev, A. E. |
Author_xml | – sequence: 1 givenname: A. E. orcidid: 0000-0003-0169-3956 surname: Khrulev fullname: Khrulev, A. E. organization: Privolzhsky Research Medical University – sequence: 2 givenname: A. A. orcidid: 0000-0001-7973-3482 surname: Nikitina fullname: Nikitina, A. A. organization: Privolzhsky Research Medical University – sequence: 3 givenname: N. S. orcidid: 0000-0003-3311-4437 surname: Khruleva fullname: Khruleva, N. S. organization: Privolzhsky Research Medical University |
BookMark | eNo9kdtKAzEQhoMoWA_PYF5gNYc9JJciHgoFL9TrMEkmNlo3S7JW-vbuVunV_DPz88H8c0aO-9QjIVecXfNGCX3DO6EqpRirBOO6kpOutDwiC9FOLeOiOSaLg-mUXJbywRjjqmukqBdk-zKgiyE6mmP5pAHcmHKhIWXqMKPNaQvFfW8gUx9Lyh6nbezpAGPEfiz0J45r6tY59RPjM_oed7MToeDsG9dIh4yVj7DZlVjogDkmf0FOAmwKXv7Xc_L2cP9691Stnh-Xd7erygneyUozJyXXGmuOXALoNmDbaq-8hel6CJpJbDsZlLXa6lpbEG1n25o3jDOl5TlZ_nF9gg8z5PgFeWcSRLMfpPxuII_RbdDoJvi6Fo3g3NZWMyWawEJrpxwblCAmVvfHcjmVkjEceJyZ_TfMHLSZgzbzN4yctNFS_gI0zYAq |
CitedBy_id | crossref_primary_10_15275_sarmj_2021_0403 crossref_primary_10_30629_2658_7947_2022_27_2_43_52 |
Cites_doi | 10.1016/j.semnephrol.2012.12.011 10.7326/0003-4819-153-1-201007060-00252 10.1007/s12975-016-0499-x 10.1093/ndt/gfu259 10.21685/2072-3032-2016-3-15 10.1002/jps.22592 10.1007/s00223-009-9297-8 10.1159/000345969 10.1161/CIRCRESAHA.116.305360 10.1152/ajpheart.01237.2010 10.1159/000381990 10.1016/j.jns.2014.03.004 10.1681/ASN.2008080824 10.1681/ASN.2009060640 10.1152/ajprenal.90742.2008 10.1093/cvr/cvs240 10.1159/000345158 10.30809/phe.4.2014.5 10.1681/ASN.2009121311 10.1093/ndt/gfr624 10.1038/ki.2008.130 10.1007/s10620-014-3428-4 10.2215/CJN.07081009 10.2215/CJN.03600807 10.1371/journal.pone.0082952 10.1161/hh2401.101070 10.1155/2015/194362 10.1053/j.jrn.2011.05.004 10.1093/ndt/gfn757 10.1016/j.jns.2014.03.006 10.3109/0886022X.2010.502279 10.1038/ki.2011.49 10.1016/j.arcmed.2014.04.002 10.1016/j.neuro.2014.06.014 10.1161/JAHA.115.002699 10.22141/2307-1257.0.1.11.2015.75397 10.1371/journal.pone.0036332 |
ContentType | Journal Article |
DBID | AAYXX CITATION DOA |
DOI | 10.15829/1728-8800-2019-3-88-93 |
DatabaseName | CrossRef Directory of Open Access Journals |
DatabaseTitle | CrossRef |
DatabaseTitleList | CrossRef |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: http://www.doaj.org/ sourceTypes: Open Website |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 2619-0125 |
EndPage | 93 |
ExternalDocumentID | oai_doaj_org_article_95fd4425211b4b90825f0f6b6195e3a2 10_15829_1728_8800_2019_3_88_93 |
GroupedDBID | 29B 5GY 642 AAYXX ABDBF ADBBV ALMA_UNASSIGNED_HOLDINGS BCNDV CITATION EAP EAS ESX GROUPED_DOAJ VCL VIT |
ID | FETCH-LOGICAL-c2173-90c33199e41e13aa96fe669d8dba829af903e673f8bb9b949ba267b6415010893 |
IEDL.DBID | DOA |
ISSN | 1728-8800 |
IngestDate | Mon Oct 21 19:33:15 EDT 2024 Fri Nov 22 00:10:31 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c2173-90c33199e41e13aa96fe669d8dba829af903e673f8bb9b949ba267b6415010893 |
ORCID | 0000-0003-3311-4437 0000-0003-0169-3956 0000-0001-7973-3482 |
OpenAccessLink | https://doaj.org/article/95fd4425211b4b90825f0f6b6195e3a2 |
PageCount | 6 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_95fd4425211b4b90825f0f6b6195e3a2 crossref_primary_10_15829_1728_8800_2019_3_88_93 |
PublicationCentury | 2000 |
PublicationDate | 2019-06-13 |
PublicationDateYYYYMMDD | 2019-06-13 |
PublicationDate_xml | – month: 06 year: 2019 text: 2019-06-13 day: 13 |
PublicationDecade | 2010 |
PublicationTitle | Kardiovaskuli͡a︡rnai͡a︡ terapii͡a︡ i profilaktika |
PublicationYear | 2019 |
Publisher | SILICEA-POLIGRAF» LLC |
Publisher_xml | – name: SILICEA-POLIGRAF» LLC |
References | ref13 ref35 ref12 ref34 ref15 ref37 ref14 ref36 ref31 ref30 ref11 ref33 ref10 ref32 ref2 ref1 ref17 ref39 ref16 ref38 ref19 ref18 ref24 ref23 ref26 ref25 ref20 ref42 ref41 ref22 ref21 ref28 ref27 ref29 ref8 ref7 ref9 ref4 ref3 ref6 ref5 ref40 |
References_xml | – ident: ref1 – ident: ref11 doi: 10.1016/j.semnephrol.2012.12.011 – ident: ref37 doi: 10.7326/0003-4819-153-1-201007060-00252 – ident: ref39 doi: 10.1007/s12975-016-0499-x – ident: ref42 doi: 10.1093/ndt/gfu259 – ident: ref5 doi: 10.21685/2072-3032-2016-3-15 – ident: ref7 – ident: ref21 doi: 10.1002/jps.22592 – ident: ref13 doi: 10.1007/s00223-009-9297-8 – ident: ref27 doi: 10.1159/000345969 – ident: ref31 doi: 10.1161/CIRCRESAHA.116.305360 – ident: ref20 doi: 10.1152/ajpheart.01237.2010 – ident: ref26 doi: 10.1159/000381990 – ident: ref40 doi: 10.1016/j.jns.2014.03.004 – ident: ref38 doi: 10.1681/ASN.2008080824 – ident: ref14 doi: 10.1681/ASN.2009060640 – ident: ref15 doi: 10.1152/ajprenal.90742.2008 – ident: ref22 doi: 10.1093/cvr/cvs240 – ident: ref9 – ident: ref36 doi: 10.1159/000345158 – ident: ref2 doi: 10.30809/phe.4.2014.5 – ident: ref17 doi: 10.1681/ASN.2009121311 – ident: ref24 doi: 10.1093/ndt/gfr624 – ident: ref10 doi: 10.1038/ki.2008.130 – ident: ref28 doi: 10.1007/s10620-014-3428-4 – ident: ref4 – ident: ref18 doi: 10.2215/CJN.07081009 – ident: ref25 doi: 10.2215/CJN.03600807 – ident: ref34 doi: 10.1371/journal.pone.0082952 – ident: ref6 – ident: ref12 doi: 10.1161/hh2401.101070 – ident: ref16 doi: 10.1155/2015/194362 – ident: ref29 doi: 10.1053/j.jrn.2011.05.004 – ident: ref23 doi: 10.1093/ndt/gfn757 – ident: ref41 doi: 10.1016/j.jns.2014.03.006 – ident: ref8 doi: 10.3109/0886022X.2010.502279 – ident: ref35 doi: 10.1038/ki.2011.49 – ident: ref30 doi: 10.1016/j.arcmed.2014.04.002 – ident: ref19 doi: 10.1016/j.neuro.2014.06.014 – ident: ref32 doi: 10.1161/JAHA.115.002699 – ident: ref33 doi: 10.22141/2307-1257.0.1.11.2015.75397 – ident: ref3 doi: 10.1371/journal.pone.0036332 |
SSID | ssj0001875324 |
Score | 2.1385462 |
Snippet | Cerebral vascular disorders are one of the leading causes of disability and mortality in patients with chronic kidney disease (CKD). The article presents the... |
SourceID | doaj crossref |
SourceType | Open Website Aggregation Database |
StartPage | 88 |
SubjectTerms | cerebrovascular disorders chronic kidney disease hyperhomocysteinemia impaired calcium-phosphorus metabolism intestinal bacteria toxins risk factors secondary amyloidosis stroke uremic toxins |
Title | Specific risk factors for cerebrovascular disorders in patients with chronic kidney disease in the pre-dialysis period |
URI | https://doaj.org/article/95fd4425211b4b90825f0f6b6195e3a2 |
Volume | 18 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV07T8MwELagEwsCAaK85IHVqhMnfoy8qk4sgMRm-SlVSClqKRL_nrvEVGViYYpjWVH83SW-cy7fR8i18ZXMyitWK-dYk7NhOtaJNVXmcFa3dV_yP3tSj6_6_gFpcjZSX1gTNtADD8BNTJtjA44FiYpvPAp0t5ln6SHwb5Nww9uXy61kqt9dwTB8ULRVtWbgpLwUd7W6NpNNJzhJZZiANjPi19K0xeDfLzXTA7JfYkR6M9zbIdlZro_IZ68Un-eBYjU4LTo5FGJOGtISMttNUSmNhVFzRecdLcSpK4o7rjQMXLj0bR679EXL5xkcB4EgxZIQ_JEEWUooUiAv4jF5mT48381YEU1gAbILwQwPAh4rk5oqVcI5I3OS0kQdvYOpu2y4SFKJrL033jTGu1oqL2Ehh9QMopcTMuoWXTolVHKvUPbbwbHxUniXdA5CBi2C0DyOCf_By74P3BgWcwqE2CLEFiG2CLEV0LZGjMkt4roZjuTWfQeY3BaT279MfvYfFzkne73tUYZIXJDRx3KdLsnuKq6velf6BtMdyN8 |
link.rule.ids | 315,782,786,866,2106,27933,27934 |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Specific+risk+factors+for+cerebrovascular+disorders+in+patients+with+chronic+kidney+disease+in+the+pre-dialysis+period&rft.jtitle=Kardiovaskuli%CD%A1a%EF%B8%A1rnai%CD%A1a%EF%B8%A1+terapii%CD%A1a%EF%B8%A1+i+profilaktika&rft.au=A.+E.+Khrulev&rft.au=A.+A.+Nikitina&rft.au=N.+S.+Khruleva&rft.date=2019-06-13&rft.pub=SILICEA-POLIGRAF%C2%BB+LLC&rft.issn=1728-8800&rft.eissn=2619-0125&rft.volume=18&rft.issue=3&rft.spage=88&rft.epage=93&rft_id=info:doi/10.15829%2F1728-8800-2019-3-88-93&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_95fd4425211b4b90825f0f6b6195e3a2 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1728-8800&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1728-8800&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1728-8800&client=summon |